EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+11.07%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.1B
AUM Growth
-$1.95B
(-64%)
Cap. Flow
-$2.1B
Cap. Flow
% of AUM
-190.3%
Top 10 Holdings %
Top 10 Hldgs %
55.43%
Holding
359
New
34
Increased
188
Reduced
93
Closed
36
Top Buys
| 1 |
STAAR Surgical
STAA
|
$42.6M |
| 2 |
Sea Limited
SE
|
$22.9M |
| 3 |
Mercado Libre
MELI
|
$19.7M |
| 4 |
NIO
NIO
|
$19.6M |
| 5 |
Meta Platforms (Facebook)
META
|
$16.1M |
Top Sells
| 1 |
Alibaba
BABA
|
$1.32B |
| 2 |
JD.com
JD
|
$334M |
| 3 |
Baidu
BIDU
|
$314M |
| 4 |
NetEase
NTES
|
$202M |
| 5 |
Trip.com Group
TCOM
|
$95M |
Sector Composition
| 1 | Consumer Discretionary | 35.58% |
| 2 | Technology | 17.59% |
| 3 | Communication Services | 16.9% |
| 4 | Healthcare | 11.23% |
| 5 | Real Estate | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Home Depot
HD
$408B
| $563K | 0.05% |
2,052
-7
| -0.3% | -$1.92K |
|
127
Merck
MRK
$209B
| $561K | 0.05% |
6,156
-145
| -2% | -$13.2K |
|
128
Novavax
NVAX
$1.19B
| $554K | 0.05% |
10,780
+7,104
| +193% | +$365K |
|
129
Fate Therapeutics
FATE
$111M
| $548K | 0.05% |
22,103
+14,107
| +176% | +$350K |
|
|
KRTX
130
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $546K | 0.05% |
4,316
+1,709
| +66% | +$216K |
|
131
PTC Therapeutics
PTCT
$4.45B
| $543K | 0.05% |
13,553
+5,723
| +73% | +$229K |
|
132
Monster Beverage
MNST
$61.8B
| $538K | 0.05% |
11,610
+112
| +1% | +$5.19K |
|
133
Intellia Therapeutics
NTLA
$1.23B
| $534K | 0.05% |
10,315
+5,938
| +136% | +$307K |
|
134
Keurig Dr Pepper
KDP
$39.2B
| $531K | 0.05% |
15,011
+1,782
| +13% | +$63K |
|
135
Thermo Fisher Scientific
TMO
$181B
| $525K | 0.05% |
966
-6
| -0.6% | -$3.26K |
|
136
Ultragenyx Pharmaceutical
RARE
$3.03B
| $524K | 0.05% |
8,779
+4,678
| +114% | +$279K |
|
137
Exelon
EXC
$43.8B
| $512K | 0.05% |
11,307
+141
| +1% | +$6.39K |
|
138
Beam Therapeutics
BEAM
$1.82B
| $512K | 0.05% |
13,237
+8,833
| +201% | +$342K |
|
139
Arrowhead Research
ARWR
$3.82B
| $505K | 0.05% |
14,347
+7,926
| +123% | +$279K |
|
140
Exelixis
EXEL
$10B
| $503K | 0.05% |
24,138
+11,358
| +89% | +$237K |
|
141
Kraft Heinz
KHC
$32B
| $499K | 0.05% |
13,088
+24
| +0.2% | +$915 |
|
|
MRTX
142
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $498K | 0.05% |
7,413
+4,092
| +123% | +$275K |
|
|
SWTX
143
DELISTED
SpringWorks Therapeutics
SWTX
| $493K | 0.04% |
20,031
+15,474
| +340% | +$381K |
|
144
Coca-Cola
KO
$296B
| $487K | 0.04% |
7,747
+164
| +2% | +$10.3K |
|
145
Alnylam Pharmaceuticals
ALNY
$59.5B
| $483K | 0.04% |
3,315
+1,583
| +91% | +$231K |
|
146
BioMarin Pharmaceuticals
BMRN
$11B
| $483K | 0.04% |
5,832
+2,301
| +65% | +$191K |
|
147
Apellis Pharmaceuticals
APLS
$3.5B
| $482K | 0.04% |
10,651
+4,455
| +72% | +$202K |
|
148
Vir Biotechnology
VIR
$732M
| $482K | 0.04% |
18,939
+6,656
| +54% | +$169K |
|
149
O'Reilly Automotive
ORLY
$88.8B
| $480K | 0.04% |
11,400
-90
| -0.8% | -$3.79K |
|
150
Abbott
ABT
$232B
| $476K | 0.04% |
4,385
-8
| -0.2% | -$868 |
|